ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Gap Up – Here’s What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shares gapped up prior to trading on Tuesday . The stock had previously closed at $20.42, but opened at $21.54. ChronoScale Corporation Common Stock shares last traded at $21.85, with a volume of 12,585 shares.

Analysts Set New Price Targets

Several brokerages recently issued reports on CHRN. Northland Securities began coverage on shares of ChronoScale Corporation Common Stock in a research note on Friday. They issued an “outperform” rating and a $32.00 price target for the company. Weiss Ratings raised ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 24th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, ChronoScale Corporation Common Stock currently has an average rating of “Hold” and an average target price of $19.00.

ChronoScale Corporation Common Stock Stock Down 1.5%

The company’s 50 day moving average price is $21.52 and its two-hundred day moving average price is $17.19. The firm has a market cap of $3.11 billion, a PE ratio of -3.97 and a beta of 0.98. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.06.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its quarterly earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The firm had revenue of $18.40 million for the quarter. On average, equities research analysts expect that ChronoScale Corporation Common Stock will post -0.1 EPS for the current fiscal year.

Institutional Trading of ChronoScale Corporation Common Stock

A hedge fund recently raised its position in ChronoScale Corporation Common Stock stock. Roble Belko & Company Inc boosted its holdings in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) by 104.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,338 shares of the company’s stock after purchasing an additional 1,195 shares during the quarter. Roble Belko & Company Inc owned about 0.07% of ChronoScale Corporation Common Stock worth $25,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.